CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ACADACADIA PHARMACEUTICALS INC

NASDAQ · Pharmaceutical Preparations
Last close $20.15 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$3.47B
RECENT INSIDER TRADES
  • 2026-08-07 · Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) · OTHER
  • 2026-08-07 · Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders382
Shares held198,129,831
Value$4.87B
Percent of shares outstanding114.99%
As of quarter end2026-06-30
RECENT NEWS
  • ACAD: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
  • RBC Capital reiterates Acadia Pharmaceuticals stock rating on patent developments
  • Why is ACADIA Pharmaceuticals stock climbing today?
  • ACAD: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
  • H.C. Wainwright lowers Acadia Pharmaceuticals price target to $33
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS